Publications by authors named "Thomas Carattini"

Claim this Profile
L
Long-Term Real-World Outcomes of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy up to 108 Weeks.
Nosheen Reza, Anandkumar Dubey, Nadim Mahmud, Melissa A Austin, Estherland Duqueney, Thomas Carattini

J Clin Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten.
Nosheen Reza, Anandkumar Dubey, Thomas Carattini, Amy Marzolf, Nicole Hornsby

JACC Heart Fail· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-infusion Costs Associated with Idecabtagene Vicleucel Treatment for Patients with Relapsed/Refractory Multiple Myeloma in the KarMMa Trial.
November McGarvey, Brian Ung, Thomas Carattini, Ken Imanak, Abraham Lee

Adv Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis